Article
Hypericin affects cancer side populations via competitive inhibition of BCRP.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Mar 2018
Vargová Jana, Mikeš Jaromír, Jendželovský Rastislav, Mikešová Lucia, Kuchárová Barbora, Čulka Ľubomír, Fedr Radek, Remšík Ján, Souček Karel, Kozubík Alois, Fedoročko Peter
Abstract excerpt
OBJECTIVE: Cancer stem-like cells (CSLCs) are considered a root of tumorigenicity and resistance. However, their identification remains challenging. The use of the side population (SP) assay as a credible marker of CSLCs remains controversial. The SP assay relies on the elevated activity of ABC transporters that, in turn, can be modulated by hypericin (HYP), a photosensitizer and bioactive compound of St. John's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
